Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Collins CD, Ivry B, Bowen JD, Cheng EM, Dobson R, Goodin DS, Lechner-Scott J, Kappos L, Galea I. Collins CD, et al. Mult Scler. 2016 Sep;22(10):1349-58. doi: 10.1177/1352458515616205. Epub 2015 Nov 12. Mult Scler. 2016. PMID: 26564998 Free PMC article. Review.
Interleukin 17F level and interferon β response in patients with multiple sclerosis.
Hartung HP, Steinman L, Goodin DS, Comi G, Cook S, Filippi M, O'Connor P, Jeffery DR, Kappos L, Axtell R, Knappertz V, Bogumil T, Schwenke S, Croze E, Sandbrink R, Pohl C. Hartung HP, et al. JAMA Neurol. 2013 Aug;70(8):1017-21. doi: 10.1001/jamaneurol.2013.192. JAMA Neurol. 2013. PMID: 23732754 Free PMC article. Clinical Trial.
Comparing the efficacy of disease-modifying therapies in multiple sclerosis.
Mitsikostas DD, Goodin DS. Mitsikostas DD, et al. Among authors: goodin ds. Mult Scler Relat Disord. 2017 Nov;18:109-116. doi: 10.1016/j.msard.2017.08.003. Epub 2017 Aug 18. Mult Scler Relat Disord. 2017. PMID: 29141791 Review.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A. Fitzgerald KC, et al. JAMA Neurol. 2015 Dec;72(12):1458-65. doi: 10.1001/jamaneurol.2015.2742. JAMA Neurol. 2015. PMID: 26458124 Clinical Trial.
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG. Schlaeger R, et al. JAMA Neurol. 2015 Aug;72(8):897-904. doi: 10.1001/jamaneurol.2015.0993. JAMA Neurol. 2015. PMID: 26053119 Free PMC article.
Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.
Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. Gelfand JM, et al. PLoS One. 2012;7(5):e36847. doi: 10.1371/journal.pone.0036847. Epub 2012 May 23. PLoS One. 2012. PMID: 22666330 Free PMC article.
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
Goodin DS, Jones J, Li D, Traboulsee A, Reder AT, Beckmann K, Konieczny A, Knappertz V; 16-Year Long-Term Follow-up Study Investigators. Goodin DS, et al. PLoS One. 2011;6(11):e22444. doi: 10.1371/journal.pone.0022444. Epub 2011 Nov 30. PLoS One. 2011. PMID: 22140424 Free PMC article.
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Goodin DS, Hartung HP, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Kappos L, Bogumil T, Knappertz V, Sandbrink R, Beckmann K, White R, Petkau J, Pohl C; BEYOND Study Group. Goodin DS, et al. Mult Scler. 2012 Feb;18(2):181-95. doi: 10.1177/1352458511418629. Epub 2011 Sep 27. Mult Scler. 2012. PMID: 21952094 Clinical Trial.
Switching multiple sclerosis patients with breakthrough disease to second-line therapy.
Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. Castillo-Trivino T, et al. PLoS One. 2011 Feb 3;6(2):e16664. doi: 10.1371/journal.pone.0016664. PLoS One. 2011. PMID: 21304907 Free PMC article.
169 results
Jump to page